Cargando…

The impact of SARS-CoV-2 variants on IBD management

Detalles Bibliográficos
Autores principales:	Segal, Jonathan P, Kumar, Aditi, Raine, Timothy, Lamb, Christopher A, Brookes, Matthew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943390/ https://www.ncbi.nlm.nih.gov/pubmed/33711289 http://dx.doi.org/10.1016/S2468-1253(21)00075-3

Ejemplares similares

Implications of recurrent SARS-CoV-2 outbreaks for IBD management
por: Segal, Jonathan P, et al.
Publicado: (2020)

Personalised medicine in IBD: don’t dispose of the sledgehammer just yet
por: Kumar, Aditi, et al.
Publicado: (2022)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

Evaluating IBD Patient-Initiated Electronic Communication During the SARS-CoV-2 Pandemic: A Single-Center Study
por: Rao, Sanjana, et al.
Publicado: (2021)

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
por: Wang, Guo-Lin, et al.
Publicado: (2021)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
por: Kissler, Stephen M., et al.
Publicado: (2021)

Rapid identification and tracking of SARS-CoV-2 variants of concern
por: Chakraborty, Debojyoti, et al.
Publicado: (2021)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

SARS-CoV-2 rapid diagnostic tests for emerging variants
por: Bekliz, Meriem, et al.
Publicado: (2021)

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
por: Evans, John P., et al.
Publicado: (2022)

SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children
por: McCrindle, Brian W., et al.
Publicado: (2023)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Prevention of COVID-19 in patients with IBD
por: Segal, Jonathan P, et al.
Publicado: (2020)

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
por: Rockett, Rebecca, et al.
Publicado: (2022)

Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern
por: Mashe, Tapfumanei, et al.
Publicado: (2021)

SARS-CoV-2 emerging variants in Africa: view from Gabon
por: Zoa-Assoumou, Samira, et al.
Publicado: (2021)

Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants
por: Zhao, Xin, et al.
Publicado: (2021)

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
por: Uriu, Keiya, et al.
Publicado: (2021)

SARS-CoV-2 antigen-detecting rapid tests for the delta variant
por: Bekliz, Meriem, et al.
Publicado: (2022)

Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom
por: Walker, A. Sarah, et al.
Publicado: (2021)

Detection of SARS-CoV-2 variants in India from UK returnees
por: Potdar, Varsha, et al.
Publicado: (2021)

Misclassification bias in estimating clinical severity of SARS-CoV-2 variants
por: Yek, Christina, et al.
Publicado: (2022)

Tracking immune correlates of protection for emerging SARS-CoV-2 variants
por: Nilles, Eric J, et al.
Publicado: (2023)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants
por: Alam, Intikhab, et al.
Publicado: (2021)

Droplets and Aerosols in the Transmission of SARS-CoV-2
por: Meselson, Matthew
Publicado: (2020)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
por: Karim, Salim S Abdool
Publicado: (2021)

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
por: Abdool Karim, Salim S., et al.
Publicado: (2021)

T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
por: Choi, Seong Jin, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o9t32ak5se1rngqhnuo75e7vrh